查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1967869

全球神经復健设备市场规模、份额、趋势和成长分析报告（2026-2034年）

Global Neurorehabilitation Devices Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 123 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计神经復健设备市场规模将从 2025 年的 27.4 亿美元成长到 2034 年的 91.8 亿美元，2026 年至 2034 年的复合年增长率为 14.36%。

由于中风、脊髓损伤和神经退化性疾病的发生率不断上升，神经復健设备市场正经历显着增长。急诊医学的进步提高了患者的生存率，从而推动了对长期康復解决方案的需求成长。机器人技术、穿戴式装置和脑刺激系统等领域的技术创新正在改变传统的治疗方法。医疗机构正在扩大设备辅助復健的应用范围，以改善復健效果并增强患者的活动能力。

人口老化和人们对早期康復益处的认识不断提高是成长要素。机器人辅助治疗和虚拟实境（VR）系统能够实现重复性、可控的运动，从而促进神经功能恢復。医疗保健支出不断增长以及政府支持復健基础设施的政策也是推动成长的因素。此外，远距復健解决方案正在扩大偏远地区和医疗资源匮乏地区获得治疗服务的机会。

展望未来，将人工智慧 (AI) 和数据分析融入復健设备有望提升治疗方案的个人化和效率。随着经济实惠的可穿戴技术日益普及，市场预计将持续成长。专注于检验临床疗效和以患者为中心的设计理念的公司将在塑造神经復健护理的未来方面发挥关键作用。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章 全球神经復健设备市场：依产品划分

  • 市场分析、洞察与预测
  • 神经机器人学
  • 脑机介面
  • 穿戴式装置
  • 非侵入性刺激器
  • 其他的

第五章 全球神经復健设备市场：依治疗领域划分

  • 市场分析、洞察与预测
  • 中风
  • 帕金森氏症
  • 多发性硬化症
  • 脑性麻痹
  • 其他的

第六章 全球神经復健设备市场：依地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第七章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商情况（基于现有资讯）
  • 策略规划

第八章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Bioventus
    • Ectron
    • Hocoma
    • Medtronic
    • Tyromotion Inc
    • Biometrics Ltd
    • Bionik Laboratories Corp.（BNKL）
    • BioXtreme Ltd
    • Ekso Bionics
    • Kinestica
    • Kinova Inc
    • Saebo Inc
    • Abbott
简介目录
Product Code: VMR11218942

The Neurorehabilitation Devices Market size is expected to reach USD 9.18 Billion in 2034 from USD 2.74 Billion (2025) growing at a CAGR of 14.36% during 2026-2034.

The neurorehabilitation devices market is witnessing significant growth due to the rising prevalence of stroke, spinal cord injuries, and neurodegenerative disorders. Improvements in emergency care have increased survival rates, creating greater demand for long-term rehabilitation solutions. Technological advancements in robotics, wearable devices, and brain stimulation systems are transforming traditional therapy methods. Healthcare providers are increasingly adopting device-assisted rehabilitation to enhance recovery outcomes and improve patient mobility.

Key drivers include the growing elderly population and increased awareness about early rehabilitation benefits. Robotic-assisted therapy and virtual reality-based systems allow repetitive, controlled movements that improve neurological recovery. Rising healthcare expenditure and government initiatives supporting rehabilitation infrastructure are also fueling growth. Additionally, tele-rehabilitation solutions are expanding access to therapy services in remote and underserved regions.

Looking forward, integration of artificial intelligence and data analytics into rehabilitation devices is expected to personalize therapy programs and improve efficiency. The market will likely expand as cost-effective wearable technologies become more accessible. Companies focusing on clinical validation and patient-centric designs will play a critical role in shaping the future of neurorehabilitation care.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Neurorobotics
  • Brain-Computer Interface
  • Wearable Devices
  • Non-Invasive Stimulators
  • Others

By Therapy Area

  • Stroke
  • Parkinson's Disease
  • Multiple Sclerosis
  • Cerebral Palsy
  • Others

COMPANIES PROFILED

  • Bioventus, Ectron, Hocoma, Medtronic, Tyromotion Inc, Biometrics Ltd, Bionik Laboratories Corp BNKL, BioXtreme Ltd, Ekso Bionics, Kinestica, Kinova Inc, Saebo Inc, Abbott
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL NEUROREHABILITATION DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Neurorobotics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Brain-Computer Interface Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Wearable Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Non-Invasive Stimulators Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NEUROREHABILITATION DEVICES MARKET: BY THERAPY AREA 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Therapy Area
  • 5.2. Stroke Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Parkinson's Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Multiple Sclerosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Cerebral Palsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NEUROREHABILITATION DEVICES MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Product
    • 6.2.2 By Therapy Area
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Product
    • 6.3.2 By Therapy Area
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Product
    • 6.4.2 By Therapy Area
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Product
    • 6.5.2 By Therapy Area
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Product
    • 6.6.2 By Therapy Area
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL NEUROREHABILITATION DEVICES INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Bioventus
    • 8.2.2 Ectron
    • 8.2.3 Hocoma
    • 8.2.4 Medtronic
    • 8.2.5 Tyromotion Inc
    • 8.2.6 Biometrics Ltd
    • 8.2.7 Bionik Laboratories Corp. (BNKL)
    • 8.2.8 BioXtreme Ltd
    • 8.2.9 Ekso Bionics
    • 8.2.10 Kinestica
    • 8.2.11 Kinova Inc
    • 8.2.12 Saebo Inc
    • 8.2.13 Abbott